Penumbra Revenue 2014-2025 | PEN
Penumbra annual/quarterly revenue history and growth rate from 2014 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Penumbra revenue for the quarter ending March 31, 2025 was $0.324B, a 16.32% increase year-over-year.
- Penumbra revenue for the twelve months ending March 31, 2025 was $1.240B, a 13.17% increase year-over-year.
- Penumbra annual revenue for 2024 was $1.195B, a 12.86% increase from 2023.
- Penumbra annual revenue for 2023 was $1.059B, a 24.95% increase from 2022.
- Penumbra annual revenue for 2022 was $0.847B, a 13.32% increase from 2021.
| Penumbra Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $1,195 |
| 2023 | $1,059 |
| 2022 | $847 |
| 2021 | $748 |
| 2020 | $560 |
| 2019 | $547 |
| 2018 | $445 |
| 2017 | $334 |
| 2016 | $263 |
| 2015 | $186 |
| 2014 | $126 |
| 2013 | $89 |
| Penumbra Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-03-31 | $324 |
| 2024-12-31 | $316 |
| 2024-09-30 | $301 |
| 2024-06-30 | $299 |
| 2024-03-31 | $279 |
| 2023-12-31 | $285 |
| 2023-09-30 | $271 |
| 2023-06-30 | $261 |
| 2023-03-31 | $241 |
| 2022-12-31 | $221 |
| 2022-09-30 | $214 |
| 2022-06-30 | $208 |
| 2022-03-31 | $204 |
| 2021-12-31 | $204 |
| 2021-09-30 | $190 |
| 2021-06-30 | $184 |
| 2021-03-31 | $169 |
| 2020-12-31 | $167 |
| 2020-09-30 | $151 |
| 2020-06-30 | $105 |
| 2020-03-31 | $137 |
| 2019-12-31 | $145 |
| 2019-09-30 | $140 |
| 2019-06-30 | $134 |
| 2019-03-31 | $128 |
| 2018-12-31 | $121 |
| 2018-09-30 | $112 |
| 2018-06-30 | $110 |
| 2018-03-31 | $103 |
| 2017-12-31 | $96 |
| 2017-09-30 | $84 |
| 2017-06-30 | $81 |
| 2017-03-31 | $73 |
| 2016-12-31 | $73 |
| 2016-09-30 | $67 |
| 2016-06-30 | $65 |
| 2016-03-31 | $58 |
| 2015-12-31 | $54 |
| 2015-09-30 | $50 |
| 2015-06-30 | $42 |
| 2015-03-31 | $39 |
| 2014-12-31 | |
| 2014-09-30 | $32 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $9.903B | $1.195B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $187.481B | 82.12 |
| Thermo Fisher Scientific (TMO) | United States | $152.647B | 18.46 |
| Edwards Lifesciences (EW) | United States | $44.494B | 29.17 |
| Alcon (ALC) | Switzerland | $43.016B | 29.07 |
| IDEXX Laboratories (IDXX) | United States | $42.664B | 49.03 |
| DexCom (DXCM) | United States | $34.337B | 53.07 |
| IQVIA Holdings (IQV) | United States | $27.434B | 15.37 |
| Mettler-Toledo (MTD) | United States | $24.631B | 29.29 |
| STERIS (STE) | Ireland | $23.569B | 25.96 |
| Waters (WAT) | United States | $20.638B | 29.12 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.019B | 0.00 |
| Hologic (HOLX) | United States | $14.447B | 15.70 |
| Sysmex ADR (SSMXY) | Japan | $10.802B | 30.64 |
| Masimo (MASI) | United States | $9.232B | 34.05 |
| Globus Medical (GMED) | United States | $7.941B | 18.92 |
| Glaukos (GKOS) | United States | $5.725B | 0.00 |
| Teleflex (TFX) | United States | $5.307B | 8.76 |
| TransMedics (TMDX) | United States | $4.486B | 97.53 |
| Integer Holdings (ITGR) | United States | $4.202B | 22.01 |
| PROCEPT BioRobotics (PRCT) | United States | $3.261B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.510B | 14.94 |
| Veracyte (VCYT) | United States | $2.105B | 29.54 |
| Nihon Kohden (NHNKY) | Japan | $1.997B | 22.90 |
| Elekta AB (EKTAY) | Sweden | $1.910B | 17.17 |
| Alphatec Holdings (ATEC) | United States | $1.659B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.344B | 0.00 |
| Artivion (AORT) | United States | $1.328B | 124.44 |
| Pulse Biosciences (PLSE) | United States | $1.036B | 0.00 |
| OPKO Health (OPK) | United States | $1.023B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.922B | 4.91 |
| IRadimed (IRMD) | United States | $0.769B | 39.02 |
| SiBone (SIBN) | United States | $0.760B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.682B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.573B | 8.91 |
| RxSight (RXST) | United States | $0.557B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.538B | 12.61 |
| OrthoPediatrics (KIDS) | United States | $0.520B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.483B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.467B | 12.43 |
| AxoGen (AXGN) | United States | $0.462B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.430B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.411B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.372B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.360B | 0.00 |
| NeuroPace (NPCE) | United States | $0.353B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.326B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.241B | 14.61 |
| 908 Devices (MASS) | United States | $0.237B | 0.00 |
| Neuronetics (STIM) | United States | $0.233B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.227B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.220B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.209B | 0.00 |
| Inogen (INGN) | United States | $0.190B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.168B | 0.00 |
| CVRx (CVRX) | United States | $0.158B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.148B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.145B | 0.00 |
| Accuray (ARAY) | United States | $0.135B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.129B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.104B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.089B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.077B | 47.10 |
| InspireMD (NSPR) | United States | $0.076B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.073B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.065B | 0.00 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.042B | 0.00 | |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.89 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |